Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “rheumatoid-arthritis” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 82
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 82 pipeline programs matching "rheumatoid-arthritis" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

82 results for “rheumatoid-arthritis” Back to intelligence hub

Search results

Page 3 of 4
  1. Stem cells

    Takeda

    Rheumatoid Arthritis Aggravated

    phase 2 gene therapy completed

    1 trial
  2. VX-702

    Vertex Pharmaceuticals (Australia) Pty.

    Rheumatoid Arthritis

    phase 2 small molecule completed

    2 trials
  3. Veltuzumab

    Takeda

    Rheumatoid Arthritis

    phase 2 small molecule terminated

    1 trial
  4. 50 mg LX3305 QD

    LEXICON PHARMACEUTICALS, INC.

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  5. AB-101

    Artiva Biotherapeutics

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial
  6. Atorvastatin

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  7. CLN-978

    Cullinan Therapeutics

    Rheumatoid Arthritis (RA

    phase 1 small molecule active

    1 trial
  8. GS-0272

    Gilead Sciences Ireland UC

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial
  9. Humanized TNFα monoclonal antibody

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  10. LD and GC012F CAR-T Cell Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial
  11. LX3305

    LEXICON PHARMACEUTICALS, INC.

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  12. No Intervention

    Takeda

    Rheumatoid Arthritis

    phase 1 other completed

    1 trial
  13. RA-TL011-101

    Teva Pharma GmbH

    Rheumatoid Arthritis

    phase 1 mab completed

    1 trial
  14. REGN88

    Regeneron UK Limited

    Rheumatoid Arthritis

    phase 1 mab completed

    3 trials
  15. UTAA91 injection

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial
  16. UTAA91 injection

    Suzhou Ribo Life Science Co.

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial
  17. namilumab (MT203)

    Takeda

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  18. sarilumab SAR153191 (REGN88)

    Sanofi Pasteur

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  19. Baricitinib 4 MG

    Chinese University of Hong Kong

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  20. Colquhounia Root Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  21. DePuy ASR Hip System

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    approved other terminated

    1 trial
  22. ETN Alone

    Universal Integrated

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial
  23. Etanercept , Methotrexate

    Wyeth is now a wholly owned subsidiary of Pfizer

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial
  24. Filgotinib

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    approved small molecule active

    8 trials

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.